Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosimilar medicines worldwide.
ALVO | LU
Overview
Corporate Details
- ISIN(s):
- LU2458332611
- LEI:
- 222100DCZBOWV5DZ8372
- Country:
- Luxembourg
- Address:
- 9, RUE DE BITBOURG, L-1273 LUXEMBOURG
- Website:
- https://www.alvotech.com/
- Sector:
- Manufacturing
Description
Alvotech is a biotechnology company that specializes in the development and manufacturing of biosimilar medicines for patients worldwide. The company's mission is to improve lives by expanding access to high-quality, affordable biologic medicines. Alvotech operates a fully integrated, end-to-end platform that encompasses the entire process from cell line development through to fill and finish manufacturing. This vertically integrated approach provides control over scale, speed, and quality. For commercialization and registration in global markets, Alvotech leverages strategic partnerships, allowing it to maintain a singular focus on its core development and manufacturing expertise. The company's product pipeline targets various therapeutic areas, including autoimmune and eye disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-24 11:30 |
Markaðsleyfi veitt á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu Alvotech v…
|
Icelandic | 8.4 KB | ||
| 2025-11-24 11:30 |
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denos…
|
English | 13.3 KB | ||
| 2025-11-20 10:00 |
Alvotech og Advanz Pharma fá markaðsleyfi á Evrópska efnahagssvæðinu fyrir Gobi…
|
Icelandic | 7.4 KB | ||
| 2025-11-20 10:00 |
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Econo…
|
English | 13.7 KB | ||
| 2025-11-12 22:40 |
Alvotech kynnir uppgjör fyrstu níu mánaða ársins 2025 og helstu áfanga í rekstr…
|
Icelandic | 24.6 KB | ||
| 2025-11-12 22:40 |
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Busin…
|
English | 29.2 KB | ||
| 2025-11-10 10:00 |
Alvotech vinnur sigur í mikilvægu dómsmáli um framleiðslu og markaðssetningu AV…
|
Icelandic | 7.9 KB | ||
| 2025-11-10 10:00 |
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market …
|
English | 10.3 KB | ||
| 2025-11-06 15:00 |
Alvotech og Advanz Pharma fá markaðsleyfi í Bretlandi fyrir Gobivaz, hliðstæðu …
|
Icelandic | 7.2 KB | ||
| 2025-11-06 15:00 |
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Bio…
|
English | 16.4 KB | ||
| 2025-11-04 22:01 |
Alvotech kynnir afkomu fyrstu níu mánaða ársins og ræðir nýjustu áfanga í rekst…
|
Icelandic | 3.7 KB | ||
| 2025-11-04 22:01 |
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for…
|
English | 5.9 KB | ||
| 2025-11-02 23:10 |
Alvotech birtir nýjar upplýsingar um stöðu umsóknar um markaðsleyfi fyrir AVT05…
|
Icelandic | 6.4 KB | ||
| 2025-11-02 23:10 |
Alvotech Provides Update on the Status of U.S. Biologics License Application fo…
|
English | 7.6 KB | ||
| 2025-10-22 11:00 |
Skipulagsbreytingar á viðskiptasviði Alvotech
|
Icelandic | 6.6 KB |
Automate Your Workflow. Get a real-time feed of all Alvotech Holdings S.A filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alvotech Holdings S.A
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alvotech Holdings S.A via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
